Introduction Glioblastomas (GBM) are devastating brain tumors and rank as one of the most aggressive human cancers with a median …
Arctoris is driven by a relentless pursuit to make drug discovery better. An industry where bringing a single drug to …
Sept. 16, 2022
There are many drug target classes for which unwanted on-target pharmacology limits clinical application. Understanding E3 tissue expression across both …
Sept. 16, 2022
A key step in the targeted protein degradation (TPD) process is the formation of an induced proximity complex, where a …
Sept. 15, 2022
In contrast to the discovery of "traditional drugs" such as small molecule inhibitors and most biologics, the development of protein …
July 21, 2022
Cyclica is designing chemical probes for DCAF1, a potentially novel target for protein degradation, with proprietary technology MatchMaker DCAF1 was …
July 14, 2022
Sponsored by Biocompare.com Every marketer feels pressure to demonstrate results for their marketing spend. Executives in the life sciences industry …
July 14, 2022
This is a sponsored case study republished from ScienceExchange.com Over the past decade, the biopharmaceutical industry has undergone a massive …
July 14, 2022
Bioz provides advanced life science experimentation insights to scientists in two key formats, first on the Bioz platform which showcases …
